PROGYNY, INC. (PGNY) News
Filter PGNY News Items
PGNY News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
PGNY News Highlights
- PGNY's 30 day story count now stands at 7.
- Over the past 21 days, the trend for PGNY's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- BEAT, CSII and EW are the most mentioned tickers in articles about PGNY.
Latest PGNY News From Around the Web
Below are the latest news stories about PROGYNY INC that investors may wish to consider to help them evaluate PGNY as an investment opportunity.
Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report?Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. |
Investors in Progyny (NASDAQ:PGNY) have made a return of 27% over the past three yearsProgyny, Inc. ( NASDAQ:PGNY ) shareholders might be concerned after seeing the share price drop 23% in the last... |
Should You Retain Progyny (PGNY) Stock?Polen Capital, an investment management company, released its “Polen U.S. Small Company Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. In the fourth quarter, the fund delivered 3.46% net of fees compared to a 4.13% return for the Russell 2000 Growth Index. Style factor headwinds and relative sector positioning offset […] |
Cardiovascular Systems (CSII) Global Sales Up, Margin Woe StaysCardiovascular Systems (CSII) international revenues are showing strong growth in each of the key markets, including Japan, Europe, Asia Pacific and Canada. |
Edwards Lifesciences (EW) Gains From Innovation Amid Cost WoeEdwards Lifesciences (EW) continues to witness strong momentum of the RESILIA portfolio globally. |
7 Stocks With a Forward P/E of 25 to Run Away FromExpensive stocks with all the warning signs of having too high a risk of missing expectations are the stocks to avoid. |
Progyny to Discuss its Strong 2022 Financial Performance at Upcoming Investor ConferenceAnticipates Results to be at the High-End of its Previously Provided Financial GuidanceAnticipates Reporting Record Fourth Quarter Operating Cash Flow of Approximately $50 Million NEW YORK, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that the Company is participating in the 41st Annual JP Morgan Healthcare Conference, where it ex |
Progyny (NASDAQ:PGNY) Is Doing The Right Things To Multiply Its Share PriceThere are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to... |
4 Unstoppable Multibaggers to Buy in 2023 and Hold for the Next DecadeThree-year revenue growth rates between 39% and 54% are projected, making these stocks prime multibagger candidates. |
ELV vs. PGNY: Which Stock Is the Better Value Option?ELV vs. PGNY: Which Stock Is the Better Value Option? |